These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Low molecular weight heparin in hemodialysis patients with a bleeding tendency. Leu JG; Chiang SS; Lin SM; Pai JK; Jiang WW Nephron; 2000 Dec; 86(4):499-501. PubMed ID: 11124600 [TBL] [Abstract][Full Text] [Related]
48. Comparative study of anticoagulation versus saline flushes in continuous renal replacement therapy. Nagarik AP; Soni SS; Adikey GK; Raman A Saudi J Kidney Dis Transpl; 2010 May; 21(3):478-83. PubMed ID: 20427872 [TBL] [Abstract][Full Text] [Related]
49. Effect of vitamin E coated dialyzers on anticoagulation requirement in hemodialyzed children. Aoun B; Janssen-Lozinska Y; Ulinski T Saudi J Kidney Dis Transpl; 2010 May; 21(3):466-70. PubMed ID: 20427870 [TBL] [Abstract][Full Text] [Related]
50. Citrate compared to low molecular weight heparin anticoagulation in chronic hemodialysis patients. Janssen MJ; Deegens JK; Kapinga TH; Beukhof JR; Huijgens PC; van Loenen AC; van der Meulen J Kidney Int; 1996 Mar; 49(3):806-13. PubMed ID: 8648924 [TBL] [Abstract][Full Text] [Related]
51. Practical Value of Anti-Xa Activity in the Evaluation of Extracorporeal Circuit Anticoagulation during Haemodialysis: Results of a Cross-Sectional Single-Centre Study. Coene KLM; Dekker MJE; Kerskes MCHM; Hengst M; Schonck MJM; Konings CJAM; Scharnhorst V Nephron; 2017; 137(3):205-211. PubMed ID: 28817831 [TBL] [Abstract][Full Text] [Related]
52. Anticoagulant efficacy of PEG-Hirudin in patients on maintenance hemodialysis. Pöschel KA; Bucha E; Esslinger HU; Ulbricht K; Nörtersheuser P; Stein G; Nowak G Kidney Int; 2004 Feb; 65(2):666-74. PubMed ID: 14717940 [TBL] [Abstract][Full Text] [Related]
53. Risk-adjusted strategies in the prevention of early arterial thrombosis following lower extremity arterial reconstruction: a comparison of unfractionated versus low molecular weight heparin. Winkler MS; Larena-Avellaneda A; Diener H; Kölbel T; Debus ES J Cardiovasc Surg (Torino); 2013 Feb; 54(1 Suppl 1):183-92. PubMed ID: 23443603 [TBL] [Abstract][Full Text] [Related]
55. Usefulness of thrombelastography for dosage monitoring of low molecular weight heparin and unfractionated heparin during hemodialysis. Shinoda T; Arakura H; Katakura M; Shirota T; Nakagawa S Artif Organs; 1990 Dec; 14(6):413-5. PubMed ID: 2177970 [TBL] [Abstract][Full Text] [Related]
56. A cross-over study of a new low molecular weight heparin (Logiparin) in hemodialysis. Koutsikos D; Fourtounas C; Kapetanaki A; Dalamanga A; Tzanatos H; Agroyannis B; Kopelias I; Bosiolis B; Rammos G; Bovoleti O; Sallum G; Darema M Int J Artif Organs; 1996 Aug; 19(8):467-71. PubMed ID: 8841845 [TBL] [Abstract][Full Text] [Related]
57. The role of the extracorporeal circuit in the trapping and degranulation of platelets. Gritters-van den Oever M; Schoorl M; Schoorl M; Bartels PC; Grooteman MP; Nubé MJ Blood Purif; 2009; 28(3):253-9. PubMed ID: 19684392 [TBL] [Abstract][Full Text] [Related]
58. [Effect of low-molecular heparin on blood coagulation]. Harenberg J; de Vries JX; Weber E; Zimmermann R Dtsch Med Wochenschr; 1984 Jun; 109(24):951-4. PubMed ID: 6734448 [TBL] [Abstract][Full Text] [Related]
59. Discordant aPTT and anti-Xa values and outcomes in hospitalized patients treated with intravenous unfractionated heparin. Price EA; Jin J; Nguyen HM; Krishnan G; Bowen R; Zehnder JL Ann Pharmacother; 2013 Feb; 47(2):151-8. PubMed ID: 23386070 [TBL] [Abstract][Full Text] [Related]
60. Heparin versus prostacyclin in continuous hemodiafiltration for acute renal failure: effects on platelet function in the systemic circulation and across the filter. Arcangeli A; Rocca B; Salvatori G; Ciancia M; De Cristofaro R; Antonelli M Thromb Res; 2010 Jul; 126(1):24-31. PubMed ID: 20185164 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]